메뉴 건너뛰기
Annals of Surgical Oncology
Volumn 18, Issue 2, 2011, Pages 598-599
In reply: Sentinel lymph node biopsy in melanoma
Author keywords

[No Author keywords available]
Indexed keywords

CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; LETTER; LOCAL ANESTHESIA; LYMPH NODE METASTASIS; MELANOMA; MICROMETASTASIS; MORBIDITY; PRACTICE GUIDELINE; QUALITY OF LIFE; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;
EID: 79951551918     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1068-2     Document Type: Letter
Times cited : (2)
References (14)
  • 1
    • 4544306921 scopus 로고    scopus 로고
    • Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now
    • DOI 10.1111/j.1365-2133.2004.06132.x
    • N Medalie AB Ackerman 2004 Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now Br J Dermatol. 151 298 307 1:STN:280:DC%2BD2cvit1Shsw%3D%3D 10.1111/j.1365-2133.2004.06132.x 15327536 (Pubitemid 39215143)
    • (2004) British Journal of Dermatology , vol.151 , Issue.2 , pp. 298-307
    • Medalie, N.1    Ackerman, A.B.2
  • 2
    • 0345707670 scopus 로고    scopus 로고
    • Sentinel Lymph Node Biopsy Has No Benefit for Patients with Primary Cutaneous Melanoma Metastatic to a Lymph Node: An Assertion Based on Comprehensive, Critical Analysis. Part II
    • DOI 10.1097/00000372-200312000-00004
    • NS Medalie AB Ackerman 2003 Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma metastatic to a lymph node: an assertion based on comprehensive, critical analysis: part II Am J Dermatopathol. 25 473 484 10.1097/00000372-200312000-00004 14631188 (Pubitemid 37466449)
    • (2003) American Journal of Dermatopathology , vol.25 , Issue.6 , pp. 473-484
    • Medalie, N.S.1    Ackerman, A.B.2
  • 3
    • 4544296593 scopus 로고    scopus 로고
    • The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma
    • DOI 10.1111/j.1365-2133.2004.06133.x
    • DL Morton AJ Cochran 2004 The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma Br J Dermatol. 151 308 319 1:STN:280:DC%2BD2cvit1ShsA%3D%3D 10.1111/j.1365-2133.2004.06133.x 15327537 (Pubitemid 39215144)
    • (2004) British Journal of Dermatology , vol.151 , Issue.2 , pp. 308-319
    • Morton, D.L.1    Cochran, A.J.2
  • 4
    • 0034237272 scopus 로고    scopus 로고
    • The argument against sentinel node biopsy for malignant melanoma
    • JM Thomas EJ Patocskai 2000 The argument against sentinel node biopsy for malignant melanoma BMJ. 321 3 4 1:STN:280:DC%2BD3czosVaksg%3D%3D 10.1136/bmj.321.7252.3 10875809 (Pubitemid 30417014)
    • (2000) British Medical Journal , vol.321 , Issue.7252 , pp. 3-4
    • Meirion Thomas, J.1    Patocskai, E.J.2
  • 6
    • 0034979375 scopus 로고    scopus 로고
    • Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: Implications for tumor biology and treatment
    • DOI 10.1038/modpathol.3880358
    • AJ Cochran DL Morton S Stern AM Lana R Essner DR Wen 2001 Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment Mod Pathol. 14 604 608 1:STN:280:DC%2BD3MzktlentA%3D%3D 10.1038/modpathol.3880358 11406663 (Pubitemid 32554086)
    • (2001) Modern Pathology , vol.14 , Issue.6 , pp. 604-608
    • Cochran, A.J.1    Morton, D.L.2    Stern, S.3    Lana, A.M.A.4    Essner, R.5    Wen, D.-R.6
  • 7
    • 33748076467 scopus 로고    scopus 로고
    • Tumour-induced immune modulation of sentinel lymph nodes
    • DOI 10.1038/nri1919, PII NRI1919
    • AJ Cochran RR Huang J Lee E Itakura SP Leong R Essner 2006 Tumour-induced immune modulation of sentinel lymph nodes Nat Rev Immunol. 6 659 670 1:CAS:528:DC%2BD28Xos12gt7w%3D 10.1038/nri1919 16932751 (Pubitemid 44298215)
    • (2006) Nature Reviews Immunology , vol.6 , Issue.9 , pp. 659-670
    • Cochran, A.J.1    Huang, R.-R.2    Lee, J.3    Itakura, E.4    Leong, S.P.L.5    Essner, R.6
  • 8
    • 0034674903 scopus 로고    scopus 로고
    • Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening
    • WC Black 2000 Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening J Natl Cancer Inst. 92 1280 1282 1:STN:280: DC%2BD3cvjvVClsg%3D%3D 10.1093/jnci/92.16.1280 10944539 (Pubitemid 30660580)
    • (2000) Journal of the National Cancer Institute , vol.92 , Issue.16 , pp. 1280-1282
    • Black, W.C.1
  • 10
    • 0019514556 scopus 로고
    • Elimination of 'lead time' bias in assessing the effect of early breast cancer diagnosis
    • PF Jacques SC Hartz RW Tuthill C Hollingsworth 1981 Elimination of "lead time" bias in assessing the effect of early breast cancer diagnosis Am J Epidemiol. 113 93 97 1:STN:280:DyaL3M7gs1Kmuw%3D%3D 7457482 (Pubitemid 11154319)
    • (1981) American Journal of Epidemiology , vol.113 , Issue.1 , pp. 93-97
    • Jacques, P.F.1    Hartz, S.C.2    Tuthill, R.W.3    Hollingsworth, C.4
  • 11
    • 0028230136 scopus 로고
    • A data-analytic approach for estimating lead time and screening benefit based on survival curves in randomized cancer screening trials
    • K Kafadar PC Prorok 1994 A data-analytic approach for estimating lead time and screening benefit based on survival curves in randomized cancer screening trials Stat Med. 13 569 586 1:STN:280:DyaK2c3psVKlug%3D%3D 10.1002/sim.4780130519 8023036 (Pubitemid 24106738)
    • (1994) Statistics in Medicine , vol.13 , Issue.5-7 , pp. 569-586
    • Kafadar, K.1    Prorok, P.C.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.